HK1120865A1 - Prognostic allergy test - Google Patents

Prognostic allergy test

Info

Publication number
HK1120865A1
HK1120865A1 HK08114114.4A HK08114114A HK1120865A1 HK 1120865 A1 HK1120865 A1 HK 1120865A1 HK 08114114 A HK08114114 A HK 08114114A HK 1120865 A1 HK1120865 A1 HK 1120865A1
Authority
HK
Hong Kong
Prior art keywords
antibodies
antigen
child
peptides
epitopes
Prior art date
Application number
HK08114114.4A
Other languages
English (en)
Inventor
Hugh A Sampson
Original Assignee
Allertein Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allertein Therapeutics Llc filed Critical Allertein Therapeutics Llc
Publication of HK1120865A1 publication Critical patent/HK1120865A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HK08114114.4A 1998-01-30 2008-12-31 Prognostic allergy test HK1120865A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7317198P 1998-01-30 1998-01-30

Publications (1)

Publication Number Publication Date
HK1120865A1 true HK1120865A1 (en) 2009-04-09

Family

ID=22112157

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01102652A HK1032262A1 (en) 1998-01-30 2001-04-12 Prognostic allergy or inflammation test.
HK08114114.4A HK1120865A1 (en) 1998-01-30 2008-12-31 Prognostic allergy test

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK01102652A HK1032262A1 (en) 1998-01-30 2001-04-12 Prognostic allergy or inflammation test.

Country Status (10)

Country Link
US (1) US6238925B1 (xx)
EP (2) EP1051626B1 (xx)
JP (1) JP4292262B2 (xx)
AT (2) ATE550665T1 (xx)
AU (1) AU741635B2 (xx)
CA (1) CA2319317C (xx)
DE (1) DE69919327D1 (xx)
ES (2) ES2229673T3 (xx)
HK (2) HK1032262A1 (xx)
WO (1) WO1999039211A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
AU2002302410A1 (en) * 2001-03-10 2002-09-24 Affina Immuntechnik Gmbh Method for identifying immune reactive epitopes on proteins
EP1631312B1 (en) * 2003-04-23 2008-09-10 Medarex, Inc. Compositions and methods for the therapy of inflammatory bowel disease
EP2662390B1 (en) 2004-06-21 2017-08-02 E. R. Squibb & Sons, L.L.C. Interferon alpha receptor 1 antibodies and their uses
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
EP2478373B1 (en) * 2009-09-14 2019-01-09 Icahn School of Medicine at Mount Sinai Methods for characterizing antibody binding affinity and epitope diversity in food allergy
WO2012135313A1 (en) * 2011-03-28 2012-10-04 University Of Massachusetts Compositions and methods for detecting allergy to a-gal epitopes
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
AU2014248090B2 (en) 2013-04-03 2018-08-02 N-Fold Llc Novel nanoparticle compositions
KR102202575B1 (ko) 2013-12-31 2021-01-13 삼성전자주식회사 메모리 관리 방법 및 장치
CN114137205A (zh) * 2014-04-03 2022-03-04 艾勒詹尼斯有限责任公司 用于检测食物***反应的肽、试剂和方法
PE20171093A1 (es) 2014-11-14 2017-08-07 Biomerica Inc Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs
EP3173789A1 (en) * 2015-11-24 2017-05-31 Helmholtz-Zentrum für Infektionsforschung GmbH Method for differentiation of immune response in an individual
EP3449255A4 (en) * 2016-04-26 2019-11-27 Biomerica, Inc. COMPOSITIONS, DEVICES AND METHODS FOR COLITIS ULCEROSA SENSITIVITY TESTS
JP7062291B2 (ja) * 2016-05-13 2022-05-16 応用酵素医学研究所株式会社 アレルギー発症リスクを予測するためのデータを収集する方法
RU2621312C1 (ru) * 2016-06-15 2017-06-01 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста
CN109313182B (zh) * 2016-06-16 2022-07-01 朋友股份有限公司 鱼***反应的抗原
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
US20230324405A1 (en) * 2020-09-07 2023-10-12 Mitsubishi Gas Chemical Company, Inc. Allergic disease determination method and determination system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
US5567594A (en) 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
EP0677105B1 (en) * 1992-12-31 2006-03-01 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor

Also Published As

Publication number Publication date
CA2319317C (en) 2006-04-18
ATE550665T1 (de) 2012-04-15
ATE426170T1 (de) 2009-04-15
JP2002502039A (ja) 2002-01-22
EP1051626A1 (en) 2000-11-15
EP1939628A1 (en) 2008-07-02
HK1032262A1 (en) 2001-07-13
AU741635B2 (en) 2001-12-06
AU2347899A (en) 1999-08-16
JP4292262B2 (ja) 2009-07-08
CA2319317A1 (en) 1999-08-05
ES2229673T3 (es) 2009-08-04
DE69919327D1 (de) 2009-11-26
DE69919327T2 (de) 2005-03-10
WO1999039211A1 (en) 1999-08-05
EP1051626B1 (en) 2009-03-18
EP1939628B1 (en) 2012-03-21
ES2383002T3 (es) 2012-06-15
US6238925B1 (en) 2001-05-29

Similar Documents

Publication Publication Date Title
HK1120865A1 (en) Prognostic allergy test
RU2004136285A (ru) Способ диагностики гепатоцеллюлярной карциномы
HK1223947A1 (zh) 用於檢測 -末端 的多克隆-單克隆 方法
Churchman et al. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor
ATE152524T1 (de) Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
CN101918445A (zh) 用于早期妊娠诊断的组合物和方法
DE69531311D1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
IL154000A (en) A method that uses antibodies to diagnose arthritis
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
DE69112225D1 (de) Immunodiagnostische probe für gelenkrheumatismus.
DE602005025559D1 (de) Diagnostischer Test für menschliches matrix Gla-Protein und seine Verwendung als Biomarker
JPH10507266A (ja) 体液中のコラーゲンの断片化パターンの評価とコラーゲンの代謝に関連する疾患の診断
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
GR3018715T3 (en) Immunological detection method
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
Phillips et al. Quantitative characterization of specificity and potency of conjugated antibody with solid-phase, antigen bead standards
Antes et al. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system
WO1998047922A3 (en) Determination of recombinant glycosylated proteins and peptides in biological fluids
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
Hamilton Molecular engineering: applications to the clinical laboratory
DE69817807D1 (de) IMMUNOASSAY UND KIT FÜR IgA ANTIKÖRPER, SPEZIFISCH FÜR ACETALDEHYD-ADDUKTE
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
EP0368674A3 (en) Immunoassay and test kits therefor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160128